Selvita names new vice president of Sales, head of North America
20 July 2021 -

Selvita, a preclinical contract research organisation in Europe, announced on Monday that it has named Dean Bornilla as its new vice president of Sales, head of North America.

In the new role, Bornilla will manage a wide scope of corporate and business development activities across North America, including developing and maintaining relationships with key strategic customers, alliance management, and the firm's strategic positioning.

Bornilla has more than 20 years of experience in the pharmaceutical industry. He has worked at Curia (formerly AMRI) as director of Business Development for Curia's Drug Discovery platform and held roles of increasing responsibility with Curia's API Manufacturing and Drug Product platforms, and most recently with the Drug Discovery and Development group as vice president of Business Development, Western US/Canada & Asia Pacific. He has served in various positions of increasing responsibility in commercial operations at Organon and Forest Laboratories (now Allergan).